Linezolid plasma and intrapulmonary concentrations in critically ill obese patients with ventilator-associated pneumonia: intermittent vs continuous administration

Gennaro De Pascale, S Fortuna, Mario Tumbarello, Sl Cutuli, Maria Sole Vallecoccia, Teresa Spanu, Giuseppe Bello, Luca Montini, Mariano Alberto Pennisi, Pierluigi Navarra, Massimo Antonelli

Risultato della ricerca: Contributo in rivistaArticolo

25 Citazioni (Scopus)

Abstract

Clinical application of an antibiotic's pharmacokinetic/pharmacodynamic (PK/PD) properties may improve the outcome of severe infections. No data are available on the use of linezolid (LNZ) continuous infusion in critically ill obese patients affected by ventilator-associated pneumonia (VAP).
Lingua originaleInglese
pagine (da-a)103-110
Numero di pagine8
RivistaIntensive Care Medicine
Volume41
Numero di pubblicazione1
DOI
Stato di pubblicazionePubblicato - 2015

All Science Journal Classification (ASJC) codes

  • Terapia Intensiva e Rianimazione

Keywords

  • Acetamides
  • Aged
  • Anti-Bacterial Agents
  • Critical Illness
  • Drug Monitoring
  • Female
  • Humans
  • Infusions
  • Intravenous
  • Linezolid
  • Male
  • Microbial Sensitivity Tests
  • Middle Aged
  • Obesity
  • Organ Dysfunction Scores
  • Oxazolidinones
  • Pneumonia
  • Prospective Studies
  • Risk Assessment
  • Rome
  • Ventilator-Associated

Fingerprint

Entra nei temi di ricerca di 'Linezolid plasma and intrapulmonary concentrations in critically ill obese patients with ventilator-associated pneumonia: intermittent vs continuous administration'. Insieme formano una fingerprint unica.

Cita questo